Hydrolysis of P2-purinoceptor agonists by a purified ectonucleotidase from the bovine aorta, the ATP-diphosphohydrolase

Biochemical Pharmacology

Volumn 51, Issue 11, 1996, Pages 1453-1460

  Picher, Maryse ^a   Sévigny, Jean ^a   D'Orléans Juste, Pédro ^b   Beaudoin, Adrien R ^a  

^a UNIVERSITÉ DE SHERBROOKE   (Canada)

^b UNIVERSITY OF SHERBROOKE   (Canada)

Author keywords

Apyrase; ATP analogues; ATP disphosphohydrolase; ectonucleotidase; nucleotide analogues; P2 purinoceptors; vasoconstriction

Indexed keywords

2 CHLOROADENOSINE 5' TRIPHOSPHATE; 2 METHYLTHIOADENOSINE TRIPHOSPHATE; ADENOSINE 5' O (2 THIODIPHOSPHATE); ADENOSINE TRIPHOSPHATE DERIVATIVE; ADENYLYLIMIDODIPHOSPHATE; ALPHA,BETA METHYLENEADENOSINE TRIPHOSPHATE; APYRASE; BETA,GAMMA METHYLENEADENOSINE TRIPHOSPHATE; NUCLEOTIDASE; NUCLEOTIDE DERIVATIVE; PURINE P2 RECEPTOR; PURINERGIC RECEPTOR STIMULATING AGENT; ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE; DRUG DERIVATIVE;

AGONIST; ANIMAL CELL; ANIMAL TISSUE; AORTA; ARTICLE; CATTLE; DEPHOSPHORYLATION; ENZYME ACTIVE SITE; ENZYME ASSAY; ENZYME KINETICS; ENZYME PURIFICATION; HYDROLYSIS; NONHUMAN; PRIORITY JOURNAL; SMOOTH MUSCLE FIBER; ANIMAL; BINDING COMPETITION; CELL MEMBRANE; COMPARATIVE STUDY; DRUG POTENTIATION; ENZYMOLOGY; ISOLATION AND PURIFICATION; KINETICS; METABOLISM;

ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE; ANIMALS; AORTA; APYRASE; BINDING, COMPETITIVE; CATTLE; CELL MEMBRANE; HYDROLYSIS; KINETICS; RECEPTORS, PURINERGIC P2;

EID: 0029664380     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/0006-2952(96)00086-X     Document Type: Article

References (55)

1. Gordon JL, Extracellular ATP: Effects, sources and fate. Biochem J 233: 309-319, 1986.
2. Lüthje J, Origin, metabolism and function of extracellular adenine nucleotides in the blood. Klin Wochenschr 67: 317-327, 1989.
3. Sévigny J and Beaudoin AR, Le monde des nucléotides extracellulaires. Méd Sci 10: 836-844, 1994.
4. Burnstock G, Purinergic mechanisms. Ann NY Acad Sci 603: 1-17, 1990.
5. 2-purinergic receptors for extracellular ATP and other nucleotides. Am J Physiol 265: C577-C606, 1993.
6. Fredholm BB, Abbracchio MP, Burnstock G, Daly JW, Kendall Harden T, Jacobson KA, Leff P and Williams M, Nomenclature and classification of purinoceptors. Pharmacol Rev 46: 143-156, 1994.
7. Cusack NJ, Pearson JD and Gordon JL, Stereoselectivity of ectonucleotidases on vascular endothelial cells. Biochem J 214: 975-981, 1983.
8. Pearson JD, Coade SB and Cusack NJ, Characterization of ectonucleotidases on vascular smooth muscle cells. Biochem J 230: 503-507, 1985.
9. Cusack NJ and Hourani SMO, Some pharmacological and biochemical interactions of the enantiomers of adenylyl 5′-(β,γ-methylene)-diphosphonate with the guinea-pig urinary bladder. Br J Pharmacol 82: 155-159, 1984.
10. Cusack NJ, Hourani SMO and Welford LA, ATP analogues and the guinea-pig urinary bladder: Pharmacological potency is related to resistance to breakdown by ectoenzymes. Br J Pharmacol 89: 514p, 1986.
11. Cusack NJ, Hourani SMO, Loizou GD and Welford LA, Pharmacological effects of isopolar phosphonate analogues of ATP on guinea-pig taenia coli and urinary bladder. Br J Pharmacol 90: 791-795, 1987.
12. Hourani SMO, Welford LA and Cusack NJ, L-AMP-PCP, an ATP receptor agonist in guinea-pig bladder, is inactive on taenia coli. Eur J Pharmacol 108: 197-200, 1985.
13. 2-purinoceptor. Eur J Pharmacol 129: 217-224, 1986.
14. 2-purinoceptors: Evidence that the dephosphorylation of ATP analogues reduces pharmacological potency. Eur J Pharmacol 141: 123-130, 1987.
15. Cascalheira JF and Sebastiao AM, Adenine nucleotide analogues, including γ-phosphate-substituted analogues, are metabolised extracellularly in innervated frog sartorius muscle. Eur J Pharmacol 222: 49-59, 1992.
16. 2-purinoceptor? Gen Pharmacol 16: 433-440, 1985.
17. 2-purinoceptors in single acutely dissociated smooth muscle cells of the rat tail artery. Drug Dev Res 31: 285, 1994.
18. Adams DJ, Adenosine 5′-triphosphate-mediated responses in mammalian intrinsic cardiac neurons. Drug Dev Res 31: 242, 1994.
19. Beaudoin AR, Sévigny J and Picher M, ATP-diphosphohy-drolases, apyrases and nucleotide phosphohydrolases: Biochemical properties and functions. In: Biomembranes (Ed. Lee AG), Vol. 5. JAI Press, Greenwich, CT, USA, in press.
20. Plesner L, Ecto-ATPases: Identities and functions. Int Rev Cytol 158: 141-214, 1995.
21. Côté YP, Quellet S and Beaudoin AR, Kinetic properties of type-II ATP diphosphohydrolase from the tunica media of the bovine aorta. Biochim Biophys Acta 1160: 246-250, 1992.
22. Côté YP, Picher M, St.-Jean P, Béliveau R, Potier M and Beaudoin AR, Identification and localization of ATP-diphosphohydrolase (Apyrase) in bovine aorta: Relevance to vascular tone and platelet aggregation. Biochim Biophys Acta 1078: 187-191, 1991.
23. Côté YP, Pavate C and Beaudoin AR, The control of nucleotides in blood vessels: Role of the ATP diphosphohydrolase (Apyrase). Curr Top Pharmacol 1: 83-93, 1992.
24. Yagi K, Arai Y, Kato N, Hirota K and Miura Y, Purification of ATP diphosphohydrolase from bovine aorta microsomes. Eur J Biochem 180: 509-513, 1989.
25. Sévigny J and Beaudoin AR, Identification of the catalytic subunit of the bovine aorta ATP-diphosphohydrolase. Drug Dev Res 31: 320, 1994.
26. Yagi K, Shinbo M, Hashizume M, Shimba LS, Karimura S and Miura Y, ATP diphosphohydrolase is responsible for ecto-ATPase and ecto-ADPase activities in bovine aorta endothelial and smooth muscle cells. Biochem Biophys Res Commun 180: 1200-1206, 1991.
27. Pearson JD, Carleton JS and Gordon JL, Metabolism of ad enine nucleotides by ectoenzymes of vascular endothelial and smooth muscle cells in culture. Biochem J 190: 421-429, 1980.
28. Côté YP, Filep JG, Battistini B, Gauvreau J, Sirois P and Beaudoin AR, Characterization of ATP-diphosphohydrolase activities in the intima and media of the bovine aorta: Evidence for a regulatory role in platelet activation in vitro. Biochim Biophys Acta 1139: 133-142, 1992.
29. Marcus AJ and Safier LB, Thromboregulation: Multicellular modulation of platelet reactivity in hemostasis and thrombosis. FASEB J 7: 516-522, 1993.
30. Baykov AA, Evtushenko OA and Avaeva SM, A malachite green procedure for orthophosphate determination and its use in alkaline phosphate-based enzyme immunoassay. Anal Biochem 171: 266-270, 1988.
31. Picher M, Caractérisation des ATP-diphosphohydrolases due système respiratoire des mammifères. Ph. D. Thesis. Sherbrooke University, Quebec, Canada.
32. Bradford M, A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254, 1976.
33. Siefert R and Schultz G, Involvement of pyrimidinoceptors in the regulation of cell functions by uridine and uracil nucleotides. Trends Pharmacol Sci 10: 365-369, 1989.
34. Stone TW, Receptors for adenosine and adenine nucleotides. Gen Pharmacol 22: 25-31, 1991.
35. O'Connor SE, Recent developments in the classification and functional significance of receptors for ATP and UTP, evidence for nucleotide receptors. Life Sci 50: 1657-1664, 1992.
36. 2y subtypes. Drug Dev Res 31: 206-219, 1994.
37. Laliberté JF and Beaudoin AR, Sequential hydrolysis of the γ-and β-phosphate groups of ATP by the ATP diphosphohydrolase from pig pancreas. Biochim Biophys Acta 742: 9-15, 1983.
38. Knowles AF, Isler RE and Reece JF, The common occurrence of ATP diphosphohydrolase in mammalian plasma membranes. Biochim Biophys Acta 731: 88-96, 1983.
39. Valenzuela MA, Lopez J, Depix M, Mancilla M, Kettlun AM, Catalan L, Chiong M, Garrido J and Traverso-Cori A, Comparative subcellular distribution of apyrase from animal and plant sources. Characterization of microsomal apyrase. Camp Biochem Physiol 93B: 911-919, 1989.
40. Sarkis JJF and Salto C, Characterization of a synaptosomal ATP diphosphohydrolase from the electric organ of Torpedo marmorata. Brain Res Bull 26: 871-876, 1991.
41. LeBel D, Poirier GG, Phaneuf S, St.-Jean P, Laliberté JF and Beaudoin AR, Characterization and purification of a calcium-sensitive ATP-diphosphohydrolase from pig pancreas. J Biol Chem 255: 1227-1233, 1980.
42. Moodie FDL, Baum H, Butterworth PJ and Peters TJ, Purification and characterization of bovine spleen ADPase. Eur J Biochem 202: 1209-1215, 1991.
43. Poelstra K, Heynen ER, Baller JFW, Hardonk MJ and Bakker WW, Modulation of anti-Thyl nephritis in the rat by adenine nucleotides. Evidence for an anti-inflammatory role for nucleotidases. Lab Invest 66: 555-563, 1992.
44. Beukers MW, Pirovano IM, Van Weert A, Kerkhof CJM, Ijzerman AP and Soudijn W, Characterization of ectoATPase on human blood cells. A physiological role in platelet aggregation? Biochem Pharmacol 46: 1959-1966, 1993.
45. Pearson JD and Gordon JL, Nucleotide metabolism by endo thelium. Annu Rev Physiol 47: 617-627, 1985.
46. Dombrowski KE, Trevillyan JM, Cone JC, Lu Y and Phillips CA, Identification and partial characterization of an ectoATPase expressed by human natural killer cells. Biochemistry 32: 6515-6522, 1993.
47. Katsuragi T, Tokunaga T, Ogawa S, Soejima O, Sato C and Furukawa T, Existence of ATP-evoked ATP release system in smooth muscles. J Pharmacol Exp Ther 259: 513-518, 1991.
48. 2X-purinoceptors in rat urinary bladder. Br J Pharmacol 112: 1151-1159, 1994.
49. Neely CF, Haile DM, Cahill BE and Kadowitz PJ, Adenosine and ATP produce vasoconstriction in the feline pulmonary-vascular bed by different mechanisms. J Pharmacol Exp Ther 258: 753-761, 1991.
50. Colman RW, Aggregin: A platelet ADP receptor that mediates activation. FASEB J 4: 1425-1435, 1990.
51. Fedan JS, Hogaboom GK, Westfall DP and O'Donnell JP, Comparison of contractions of the smooth muscle of the guinea-pig vas deferens induced by ATP and related nucleotides. Eur J Pharmacol 81: 193-204, 1982.
52. 3), an ATP antagonist, on responses of the smooth muscle of the guinea-pig vas deferens to ATP and related nucleotides. Eur J Pharmacol 85: 277-290, 1982.
53. 2X-purinoceptor ligands. Br J Pharmacol 113: 1432-1438, 1994.
54. Crack BE, Pollard CE, Beukers MW, Roberts SM, Hunt SF, Ingall AH, McKechnie KCW, Ijzerman AP and Leff P, Pharmacological and biochemical analysis of FPL 67156, a novel, selective inhibitor of ecto-ATPase. Br J Pharmacol 114: 475-481, 1995.
55. Leff P, New ATP analogues: Pharmacological tools and potential drugs. Drug Dev Res 31: 290, 1994.